Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasms, Plasma Cell × 13-valent pneumococcal vaccine × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Granulocyte Colony-Stimulating Factor 2 inebilizumab 1 fludarabine 1 Sirolimus 1 Positron-Emission Tomography 1 Pemetrexed 1 Lenalidomide 1 Interleukin-6 1 Hyperbaric Oxygenation 1 Hydroxychloroquine 1 Filgrastim 1 Dexamethasone 1 Cyclophosphamide 1 Bortezomib 1 Blood Specimen Collection 1 13-valent pneumococcal vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02851056 2022-11-14

Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡